Effectiveness of tissue microarray technique for the assessment of estrogen and progesterone receptors expression in endometrioid endometrial cancer - preliminary report;Efektywność zastosowania techniki mikromacierzy tkankowych do oceny ekspresji receptorów estrogenowych i progesteronowych w gruczolakoraku endometrioidalnym endometrium - doniesienie wstȩpne

Ginekologia Polska

Volumn 83, Issue 5, 2012, Pages 342-346

  Gottwald, Leszek ^a   Sek, Piotr ^b   Kubiak, Robert ^b   Pasz Walczak, Grazyna ^b   Piekarski, Janusz ^b   Szwalski, Jaroslaw ^a   Suzin, Jacek ^b   Tylinski, Wieslaw ^b   Hendzel, Katarzyna ^a   Jeziorski, Arkadiusz ^b  

^a Wojewódzki Specjalistyczny Szpital im M Kopernika ^*  (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cancer endometrial endometrioid; Estrogen receptor; Microarray analysis; Progesterone receptor; Tissue microarrays

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BIOPSY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; TISSUE MICROARRAY;

ADULT; BIOPSY; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864498801     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Voduc D, Kenney C, Nielsen T. Tissue microarrays in clinical oncology. Semin Radiat Oncol. 2008, 18,89-97.
2. Takikita M, Chung J, Hewitt S. Tissue microarrays enabling high-throughput molecular pathology. Curr Opin Biotechnol. 2007, 18, 318-325.
3. Chen W, Foran D. Advances in cancer tissue microarray technology: towards improved understanding and diagnostics. Anal Chim Acta. 2006, 564, 74-81.
4. Gulmann C, O'Grady A. Tissue microarrays: an overview. Curr Diagn Pathol. 2003, 9, 149-154.
5. Kononen J, Bubendorf L, Kallioniemi A, [et al.]. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998, 4, 844-847.
6. Kim J, Lim S, Park K, [et al.]. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecol Oncol. 2005, 97, 337-341.
7. Egervari K, Szollosi Z, Nemes Z. Tissue microarray technology in breast cancer HER2 diagnostics. Pathol Res Pract. 2007, 203, 169-177.
8. Hassan S, Ferrario C, Mamo A, Basik M. Tissue microarrays: emerging standard for biomarker validation. Curr Opin Biotech. 2008, 19, 19-25.
9. Cimbaluk D, Rotmensch J, Scudiere J, [et al.]. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. Gynecol Oncol. 2007, 105, 138-144.
10. Fowler J, Ramirez M, Cohn D, [et al.]. Correlation of cyclooxygenae-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am J Obstet Gynecol. 2005, 192, 1262-1273.
11. Huang G, Arend R, Li M, [et al.]. Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma. Am J Obstet Gynecol. 2009, 200, 457.e1-5.
12. Mhawech-Fauceglia P, Herrmann F, Andrews C, [et al.]. 14-3-3s expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis. EJSO. 2009, 35, 763-767.
13. Jongen V, Briët J, de Jong R, [et al.]. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol. 2009, 112, 537-542.
14. Mirlacher M, Simon R. Recipient block in TMA technique. Methods Mol Biol. 2010, 664,37-44.
15. Tzankov A, Went P, Zimpfer A, Dirnohofer S. Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol. 2005, 40, 737-744.
16. Tennstedt P, Köster P, Brüchmann A, [et al.]. The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers. Int J Oncol. 2012, 40, 261-268.
17. Zaklad Epidemiologii i Prewencji Nowotworów Centrum Onkologii - Instytut w Warszawie. Krajowa baza danych nowotworowych. Nowotwory zlosliwe w Polsce w 2008 roku. http://www. onkologia.org.pl.
18. Gottwald L, Chalubinska J, Moszynska-Zielinska M, [i wsp.]. Gruczolakorak endometrium typu endometrioidalnego - analiza wartosci prognostycznej wybranych parametrów klinicznych i histopatologicznych. Ginekol Pol. 2011, 82, 743-748.
19. Allred D, Harvey J, Bernardo M, Clarck B. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998, 11, 155-168.
20. Shergill I, Shergill N, Araya M, Patel H. Tissue microarrays: a current medical research tool. Curr Med Res Opin. 2004, 20, 707-712.
21. Karnat A, Younes P, Sayeeduddin M, [et al.]. Protein expression profiling of endometriosis: validation of 2-tissue microarrays. Fertil Steril. 2004, 82, 1681-1683.
22. Lugli A, Forster Y, Haas P, [et al.]. Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissues samples. Hum Pathol. 2003, 34, 994-1000.
23. Goldman T, Drömann D, Marzouki M, [et al.]. Tissue microarrays from HOPE-fixed specimens allow for enhanced high throughput molecular analyses in paraffin-embedded material. Pathol Res Pract. 2005, 201, 599-602.
24. Markova I, Duskova M, Lubusky M, [et al.]. Selected immunohistochemical prognostic factors in endometrial cancer. Int J Gynecol Cancer. 2010, 20, 576-582.
25. Srijaipracharoen S, Tangjitgamol S, Tanvanich S, [et al.]. Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study. Asian Pac J Cancer Prev. 2010, 11, 215-220.
26. Simon R, Mirlacher M, Sauter G. Tissue microarrays for early target evaluation. Drug Discovery Today: Technologies. 2004, 1, 41-48.
27. Chang E, Lee A, Lee E, [et al.]. HER2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies. J Korean Med Sci. 2004, 19, 390-396.
28. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest. 2001, 81, 1331-1338.
29. Mucci N, Akdas G, Manely S, Rubin M. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heteroenous protein expression. Hum Pathol. 2000, 31, 406-414